ClinicalTrials.gg
CompletedNCT05165134RCTUpdated Dec 21, 2021

Hallux Valgus Conservative Treatment

An interventional study of Kinesiotape in Hallux Valgus, sponsored by University of Jazan. Completed at 1 site in Saudi Arabia. Open to participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2021-12-21.

Sponsored by University of Jazan · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Aug 2020, registered Dec 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
20 Years to 40 Years
Sex
All
01

Study summary

Studying the effect of kinesiotape on hallux valgus angle and pain in hallux valgus patients.

Read the detailed description

30 patients (male and female) suffering from bilateral Halux valgus. Divided randomly into 2 groups

  1. st group receive kinesiotape bilaterally for correction : Hallux valgus angle (HVA) was measured using Xray and pain was measured using VAS before applying tape and after 8 weeks of tape application.
  2. nd group receive placebo tape bilaterally and had the same measurements.

2 groups were on a group of exercises

02

Conditions studied

  • Hallux Valgus

Browse trials for

03

In context

Hallux Valgus

157 studies on the registry are indexed under Hallux Valgus; 36 are open to participants now.

This study's enrollment of 30 is below the median of 58 across 119 interventional studies indexed under Hallux Valgus.

Browse Hallux Valgus studies →

Lead sponsor

University of Jazan is the lead sponsor of 33 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • mobile hallux valgus

Exclusion criteria

Exclusion Criteria:

  • using orthotics
  • knee malalignment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Experimental kinesiotape group A

    Kinesiotape group

    Other: Kinesiotape

  • Placebo comparator
    Placebo kinesiotape group B

    Control group

    Other: Kinesiotape

Interventions

  • OtherKinesiotape

    Elastic tape used for mechanical correction of the deformity in study group and placebo in control group

06

What researchers measure

Primary outcomes

  1. Hallux valgus angle (HVA )

    Hallux valgus angle measured by x ray

    Time frame: 8 weeks

  2. Pain on metatarsophalangeal joint measured by visual analogue scale (VAS)

    Time frame: 8 weeks

07

Study locations

1 site
  • Jazan University
    Gizan, Jazan 45142, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: Yes — All will be accessible on request

Supporting information: Study protocol

Time frame: March 2022

Access criteria: Thru e mail

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2020 to primary completion in Jan 2021, 5 months.

Of 51 non-industry interventional studies with no phase under Hallux Valgus, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 55. This study's 5 months is below that.

Counting every sponsor, half of 56 studies reached it within 26 months; a quarter within 11 and three quarters within 55.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 5, 2021
First posted
Dec 21, 2021
StartActual
Aug 24, 2020
Primary completionActual
Jan 29, 2021
CompletionActual
Nov 15, 2021
Last update
Dec 21, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 21, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05165134
Lead sponsor
University of Jazan
Responsible party
Mohammed Moustafa (assistant Professor of physical therapy, University of Jazan) — Principal investigator
First posted
Dec 21, 2021
Start date
Aug 24, 2020
Primary completion
Jan 29, 2021
Completion
Nov 15, 2021
Last update
Dec 21, 2021

Study contacts

Mohamed M Ahmed
principal investigator · Assistant Professor of physical therapy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion